Just in:
Geely’s i-HEV Intelligent Hybrid Technology Offers a New Direction Vision for Gasoline-Powered Vehicles // Millions Of Indians May Soon Be Deprived Of Government Assistance // Xi Jinping Preparing For A Trilateral Summit With Trump And Putin At APEC Summit On Nov 18-19 // Beyond the exhibition floor: How robots, AI and networks are moving into the real world // Private varsities bill all set to face the axe // Ousted top Kochi cop gets IG post // Emaar approves Development buyout ahead of planned delisting // UK air traffic outage inflicted £33m financial losses // Oil advances towards $100 as tanker attacks persist // Dubai boat show confirms international shipyard line-up for November // Oil and chip shares retreat after Democratic victories // OpenAI introduces GPT-6 Cyber with restricted security access // Miss Universe Hong Kong Jen Zhou Departs for Puerto Rico to Compete in the 75th Miss Universe World Final // CR Longdation Aethereal Cybersecurity × Global Cybersecurity Alliance (GCSA) Join Hands to Establish the “AI and Cybersecurity Research Centre” // Geely’s i-HEV Intelligent Hybrid Technology Offers a New Direction for Gasoline-Powered Vehicles // The “1st Greater Bay Area Health and Longevity Summit & Awards Ceremony” concludes successfully in Macao // Meraas showcases five residential zones at Dubai Design Week // Kochi police detain two actors over bid to honey trap doctor // Cloudflare unveils Zero Wire vulnerability intelligence service // Dubai details five-year visa benefits for returning visitors //

UNC advances RNAi potency platform

Researchers at the University of North Carolina at Chapel Hill have unveiled a platform technology designed to strengthen the potency of RNA interference therapies, a field that has promised targeted gene silencing yet has struggled with delivery efficiency and durability inside cells. The work centres on improving how small interfering RNA molecules reach the cytoplasm, where they can shut down disease-driving genes with greater precision.

RNA interference, or RNAi, works by harnessing a natural cellular process to degrade specific messenger RNA strands before they can be translated into proteins. While the concept is well established and several RNAi drugs have reached the clinic, their effectiveness has often been limited by the challenge of delivering fragile RNA molecules intact to the right tissues and then releasing them from endosomal compartments once inside cells. UNC’s new platform addresses this bottleneck by combining chemical design with delivery engineering to amplify the biological impact of each dose.

According to researchers involved in the work, the technology focuses on enhancing endosomal escape, a stage where many RNAi candidates lose potency. After entering a cell, therapeutic RNA frequently becomes trapped in vesicles that ferry cargo for degradation. The UNC approach modifies carrier materials so they respond to the cellular environment, altering charge or structure in a way that disrupts the endosome and releases RNA into the cytoplasm. This mechanism allows a higher fraction of administered RNA to reach its target machinery.

Laboratory studies have shown that the platform can significantly increase gene-silencing efficiency at lower doses compared with conventional delivery systems. By improving potency, the technology could reduce the amount of RNA required for therapeutic effect, potentially lowering costs and minimising side effects linked to higher systemic exposure. Researchers say the platform has demonstrated consistent performance across different RNA sequences, suggesting broad applicability rather than a one-off optimisation for a single target.

The development comes as RNA-based medicines gain momentum across the biotechnology sector. Advances in messenger RNA vaccines have accelerated interest in nucleic-acid therapies more broadly, while RNAi continues to attract investment for its ability to address previously undruggable targets. However, delivery remains the primary hurdle separating promising laboratory results from reliable clinical outcomes. UNC’s work aligns with an industry-wide push to refine carriers, from lipid nanoparticles to polymer-based systems, that can safely and efficiently shuttle RNA into cells.

Beyond potency, the UNC platform emphasises modularity. Researchers describe a system that can be tuned for different tissues by adjusting chemical components, allowing developers to tailor delivery profiles without redesigning the core technology. Such flexibility is viewed as critical for translating RNAi into treatments for diverse conditions, ranging from rare genetic disorders to metabolic and inflammatory diseases.

Academic experts note that stronger delivery platforms could also widen the therapeutic window for RNAi. Enhanced intracellular release may enable intermittent dosing schedules or support combination therapies where RNAi is paired with small molecules or biologics. This could be particularly relevant in oncology and neurology, where sustained gene modulation is often required but systemic toxicity has constrained earlier RNA-based approaches.

Commercialisation pathways are already being explored. The university has a track record of translating nucleic-acid innovations through licensing and spin-out ventures, and the platform nature of the technology is likely to appeal to pharmaceutical partners seeking adaptable delivery solutions. Industry analysts say such partnerships are essential for scaling manufacturing, navigating regulatory pathways and validating safety in larger studies.

The timing is notable as regulators gain more experience evaluating RNA-based medicines. Clearer guidance on quality control, biodistribution and long-term effects has lowered some barriers that once slowed development. A delivery platform that can demonstrate reproducible potency improvements may benefit from this maturing regulatory environment, particularly if it can be integrated with established manufacturing processes.



Notice an issue?

Arabian Post strives to deliver the most accurate and reliable information to its readers. If you believe you have identified an error or inconsistency in this article, please don't hesitate to contact our editorial team at editor[at]thearabianpost[dot]com. We are committed to promptly addressing any concerns and ensuring the highest level of journalistic integrity.


Loading next story…
Just in:
Beyond the exhibition floor: How robots, AI and networks are moving into the real world // Miss Universe Hong Kong Jen Zhou Departs for Puerto Rico to Compete in the 75th Miss Universe World Final // Emaar approves Development buyout ahead of planned delisting // Asia Left Behind: Ten international companies have yet to report delivering on their cage-free egg pledges across the region // Technology shares plunge as Nasdaq enters correction // Trump’s Iran War Has A Share Of Contribution To His Midterm Debacle // Millions Of Indians May Soon Be Deprived Of Government Assistance // Meraas showcases five residential zones at Dubai Design Week // Cloudflare unveils Zero Wire vulnerability intelligence service // CR Longdation Aethereal Cybersecurity × Global Cybersecurity Alliance (GCSA) Join Hands to Establish the “AI and Cybersecurity Research Centre” // Oil advances towards $100 as tanker attacks persist // Kochi police detain two actors over bid to honey trap doctor // Emirates Group records AED 4.1 billion half-year profit // Xi Jinping Preparing For A Trilateral Summit With Trump And Putin At APEC Summit On Nov 18-19 // Hong Kong mandates crypto transaction disclosures to tax authorities // After Reaching 7 Million Users in the Philippines, Skyro Launches Transparent Cash Loans in Malaysia // Private varsities bill all set to face the axe // OpenAI introduces GPT-6 Cyber with restricted security access // Dubai boat show confirms international shipyard line-up for November // Dubai details five-year visa benefits for returning visitors //